Pharmaceutical firm Jubilant Life Sciences has repaid nearly Rs 900 crore ($202 million) for redemption of outstanding overseas bonds. After the repayment of its last FCCBs amounting to $202 million, there are no major debt repayments due for the next 3 years. The company has repaid all the outstanding FCCBs on time in line with terms and conditions of the FCCB instruments.